Literature DB >> 1314023

Epstein-Barr virus-associated gastric adenocarcinoma.

D Shibata1, L M Weiss.   

Abstract

The Epstein-Barr virus (EBV) has been detected in certain types of lymphoma and some epithelial neoplasms including nasopharyngeal lymphoepithelioma, and rare lymphoepithelioma-like carcinomas occurring in a variety of organs including, most recently, the stomach. The authors investigated the possibility that EBV may be present not only in the rare gastric cancers that resemble nasopharyngeal lymphoepithelioma, but also in typical gastric adenocarcinoma. EBV sequences were detected in 22 of 138 (16%) cases of typical gastric adenocarcinoma by polymerase chain reaction and in situ hybridization (ISH) techniques. The EBV genomes were specifically present within the gastric carcinoma cells in an even distribution. The EBV genomes were also present in adjacent dysplastic epithelium but were absent in surrounding lymphocytes, other normal stromal cells, intestinal metaplasia, and normal gastric mucosa. The EBV genomes in the infected gastric carcinoma cells are expressed as EBV RNA was detected by ISH. EBV was most often detected in gastric tumors from men (21%) compared with women (3%). Thus some cases of gastric adenocarcinoma are EBV-associated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314023      PMCID: PMC1886378     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Detection of herpes simplex virus using the polymerase chain reaction followed by endonuclease cleavage.

Authors:  B B Rogers; S L Josephson; S K Mak
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

2.  Salivary gland cancer in Alaskan natives, 1966-1980.

Authors:  S Krishnamurthy; A P Lanier; P Dohan; J F Lanier; W Henle
Journal:  Hum Pathol       Date:  1987-10       Impact factor: 3.466

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations.

Authors:  H Watanabe; M Enjoji; T Imai
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

5.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

6.  Prospective study of cancer in patients with hypogammaglobulinaemia.

Authors:  L J Kinlen; A D Webster; A G Bird; R Haile; J Peto; J F Soothill; R A Thompson
Journal:  Lancet       Date:  1985-02-02       Impact factor: 79.321

7.  Precursors of gastric and esophageal cancer.

Authors:  P Correa
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

8.  Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.

Authors:  J G Howe; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.

Authors:  B Z Katz; N Raab-Traub; G Miller
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

10.  Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma.

Authors:  D Shibata; L M Weiss; B N Nathwani; R K Brynes; A M Levine
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

View more
  187 in total

1.  Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan.

Authors:  M Tanaka; Y Kawaguchi; J Yokofujita; M Takagi; Y Eishi; K Hirai
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

Review 2.  Gammaherpesviruses and "Hit-and-Run" oncogenesis.

Authors:  R F Ambinder
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

4.  In situ detection of Epstein Barr virus in gastric carcinoma tissue in China high-risk area.

Authors:  Rong Wan; Mei-Qin Gao; Ling-Yun Gao; Bi-Feng Chen; Qian-Kun Cai
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

5.  No direct role for Epstein-Barr virus in American hepatocellular carcinoma.

Authors:  P G Chu; Y Y Chen; W Chen; L M Weiss
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 7.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

8.  The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.

Authors:  Chi-Neu Tsai; Chia-Lung Tsai; Ka-Po Tse; Hwan-You Chang; Yu-Sun Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

9.  Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms.

Authors:  Na Cheng; Da-yang Hui; Yong Liu; Na-na Zhang; Ye Jiang; Jing Han; Hai-Gang Li; Yun-Gang Ding; Hong Du; Jian-Ning Chen; Chun-Kui Shao
Journal:  Gastric Cancer       Date:  2014-04-27       Impact factor: 7.370

10.  Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa.

Authors:  S Shousha; Y A Luqmani
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.